96 related articles for article (PubMed ID: 194866)
1. Detection localization of Epstein-Barr virus-associated early antigens in single cells by autoradiography using 125I-labeled antibodies. (With 1 color plate).
Moar MH; Siegert W; Klein G
Intervirology; 1977; 8(4):226-39. PubMed ID: 194866
[TBL] [Abstract][Full Text] [Related]
2. Autoradiographic detection of Epstein-Barr virus (EBV)-associated early antigen in a variety of EBV DNA-containing lymphoblastoid cell lines previously designated as nonproducers.
Moar MH; Siegert W; Klein G
Intervirology; 1978; 9(6):333-43. PubMed ID: 204604
[TBL] [Abstract][Full Text] [Related]
3. Abortive expression of the Epstein-Barr virus (EBV) cycle in a variety of EBV DNA-containing cell lines, as reflected by nucleic acid hybridization in situ.
Moar MH; Klein G
Int J Cancer; 1979 Nov; 24(5):679-87. PubMed ID: 93584
[TBL] [Abstract][Full Text] [Related]
4. [Demonstration of IgG- and IgA-antibodies against Epstein-Barr virus-associated antigens with a microtiter enzyme immunoassay system. The determination of serum antibodies against the viral capsid antigen and the early antigen complex in the sera of tumor and infectious mononucleosis patients].
Dölken G; Bitzer M; Bross KJ; Brugger W; Boldt C; Hirsch FW; Weitzmann U; Löhr GW
Dtsch Med Wochenschr; 1984 Nov; 109(48):1837-43. PubMed ID: 6094138
[TBL] [Abstract][Full Text] [Related]
5. Production of rabbit antibodies against the viral capsid antigen (VCA) of the Epstein-Barr virus (EBV).
Vestergaard BF; Hesse J; Norrild B; Klein G
Int J Cancer; 1978 Mar; 21(3):323-8. PubMed ID: 75856
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity of Epstein-Barr virus. IV. Induction of a specific antigen by EBV from two transformed marmoset cell lines in Ramos cells.
Fresen KO; Cho MS; zur Hausen H
Int J Cancer; 1978 Aug; 22(2):160-5. PubMed ID: 81181
[TBL] [Abstract][Full Text] [Related]
7. Differential induction of Epstein-Barr virus-related antigens in heterokaryon cultures.
Yamamoto K; Osato T
Int J Cancer; 1977 Jun; 19(6):767-74. PubMed ID: 194844
[TBL] [Abstract][Full Text] [Related]
8. Antigen-inducing ability of herpesvirus papio in human and baboon lymphoma lines, compared to Epstein-Barr virus.
Klein G; Falk L; Falk K
Intervirology; 1978; 10(3):153-64. PubMed ID: 210135
[TBL] [Abstract][Full Text] [Related]
9. Native early antigen of Epstein-Barr virus, a promising antigen for diagnosis of nasopharyngeal carcinoma.
Paramita DK; Fachiroh J; Artama WT; van Benthem E; Haryana SM; Middeldorp JM
J Med Virol; 2007 Nov; 79(11):1710-21. PubMed ID: 17854043
[TBL] [Abstract][Full Text] [Related]
10. Establishment of EBNA-expressing cell lines by infection of Epstein-Barr virus (EBV)-genome-negative human lymphoma cells with different EBV strains.
Fresen KO; Hausen H
Int J Cancer; 1976 Feb; 17(2):161-6. PubMed ID: 175026
[TBL] [Abstract][Full Text] [Related]
11. Detection of virus and cellular-determined antigens in situ using [125I]protein A and autoradiography.
Moar MH; Rosén A; Klein G
J Immunol Methods; 1979; 30(3):219-29. PubMed ID: 227963
[TBL] [Abstract][Full Text] [Related]
12. Enzyme-linked immunosorbent assay for IgG antibodies to Epstein-Barr virus-associated early antigens and viral capsid antigen.
Dölken G; Weitzmann U; Boldt C; Bitzer M; Brugger W; Löhr GW
J Immunol Methods; 1984 Mar; 67(2):225-33. PubMed ID: 6323578
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus-induced membrane antigens: immunochemical characterization of Triton X-100 solubilized viral membrane antigens from EBV-superinfected Raji cells.
Qualtiere LF; Pearson GR
Int J Cancer; 1979 Jun; 23(6):808-17. PubMed ID: 89099
[TBL] [Abstract][Full Text] [Related]
14. Immunofluorescence and anti-complement immunofluorescence absorption tests for quantitation of Epstein-Barr virus-associated antigens.
Reedman BM; Hilgers J; Hilgers F; Klein G
Int J Cancer; 1975 Apr; 15(4):566-71. PubMed ID: 166941
[TBL] [Abstract][Full Text] [Related]
15. Characterization of Epstein-Barr virus (EBV) antigens II. Detection of early antigen (S) using anticomplement immunofluorescence (ACIF) et complement fixation (CF) tests.
Lenoir G; Berthelon MC; Favre MC; De-Thé G
Biomedicine; 1975 Dec; 23(10):461-4. PubMed ID: 177116
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus antibodies in patients with ataxia-telangiectasia and other immunodeficiency diseases.
Joncas JH; Wills A; Reece E; Fox Z
Can Med Assoc J; 1981 Oct; 125(8):845-9. PubMed ID: 6272957
[TBL] [Abstract][Full Text] [Related]
17. [IgA antibodies against Epstein-Barr virus capsid antigen].
Chalupa P; Slesinger P; Krchnáková A; Prásek J
Cas Lek Cesk; 1992 Sep; 131(17):526-9. PubMed ID: 1330312
[TBL] [Abstract][Full Text] [Related]
18. The detection of the Epstein-Barr virus (EBV) nuclear antigen (EBNA) by anticomplement immunofluorescence. Immunoglobulin class of antibodies and role of complement.
Liabeuf A; Nelson RA; Kourilsky FM
Int J Cancer; 1975 Apr; 15(4):533-46. PubMed ID: 166939
[TBL] [Abstract][Full Text] [Related]
19. [A comparison of the detection of IgM antibodies against the viral capsid antigen (VCA) of EBV (Epstein-Barr virus) in various groups of patients, using indirect immunofluorescence, indirect ELISA and reverse ELISA. Study of the diagnostic efficacy of the anti-VCA EBV IgM ELISA-VIDITEST kit].
Pumannová M; Rezbová M; Svecová M; Hrbácková H; Novotná M; Ochotná J; Roubalová K
Klin Mikrobiol Infekc Lek; 2004 Aug; 10(4):186-90. PubMed ID: 15328576
[TBL] [Abstract][Full Text] [Related]
20. Effect of adenine arabinoside on Epstein-Barr virus in vitro.
Coker-Vann M; Dolin R
J Infect Dis; 1977 Mar; 135(3):447-53. PubMed ID: 191542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
